Humoral and cellular immune response after severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid vaccination in heart transplant recipients: An observational study in France

INTRODUCTION: Heart transplant (HT) recipients have a high risk of developing severe COVID-19. Immunoglobulin G antibodies are considered to provide protective immunity and T-cell activity is thought to confer protection from severe disease. However, data on T-cell response to mRNA vaccination in a...

Descripción completa

Detalles Bibliográficos
Autores principales: Casenaz, Alice, Grosjean, Sandrine, Aho-Glélé, Ludwig-Serge, Bour, Jean-Baptiste, Auvray, Christelle, Manoha, Catherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9643719/
https://www.ncbi.nlm.nih.gov/pubmed/36388890
http://dx.doi.org/10.3389/fmed.2022.1027708

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9643719/
https://www.ncbi.nlm.nih.gov/pubmed/36388890
http://dx.doi.org/10.3389/fmed.2022.1027708

Ejemplares similares